An intensive care chemo- or chemoimmunotherapy regimen for patients with intermediate and poor-prognosis acute lymphatic leukemia and leukemic lymphoblastic lymphosarcoma: preliminary results with 14-month median follow-up.
作者信息
Misset J L, De Vassal F, Delgado M, Ribaud P, Musset M, Dorval T, Machover D, Jasmin C, Hayat M, Schwarzenberg L, Mathe G
出版信息
Recent Results Cancer Res. 1982;80:29-35. doi: 10.1007/978-3-642-81685-7_6.
